Similar articles

• Quantitative cytochemical investigations on Ehrlich ascites tumour cells treated with vincristine. IV. Interference microscopic investigations.

  Gyeskó A, Szentirmay Z, Sugár J. Gyeskó A, et al. Neoplasma. 1973;20(1):37-45. Neoplasma. 1973. PMID: 4702204 No abstract available.
• Quantitative cytochemical investigations on Ehrlich ascites tumour cells treated with Vincristine. I. Feulgen cytophotometric investigations.

  Szentirmay Z, Gyeskó A, Sugár J. Szentirmay Z, et al. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1972;78(1):82-9. doi: 10.1007/BF00284316. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1972. PMID: 4263845 No abstract available.
• Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells.

  Skovsgaard T. Skovsgaard T. Cancer Res. 1978 Dec;38(12):4722-7. Cancer Res. 1978. PMID: 719649 No abstract available.
• Quantitative cytochemical investigations on Ehrlich ascites tumour cells treated with Vincristine. II. Fast green cytophotometric investigations.

  Gyeskó A, Szentirmay Z, Sugár J. Gyeskó A, et al. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1972;78(1):90-8. doi: 10.1007/BF00284317. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1972. PMID: 4263846 No abstract available.
• The mechanism of action of methotrexate. II. Augmentation by vincristine of inhibition of deoxyribonucleic aic synthesis by methotrexate in Ehrlich ascites tumor cells.

  Goldman ID, Fyfe MJ. Goldman ID, et al. Mol Pharmacol. 1974 Mar;10(2):275-82. Mol Pharmacol. 1974. PMID: 4859543 No abstract available.